re: Ann: Prestigious Analyst Group Consilium ... I dont know why we would like a takeover would we prefer sales and iSonea into the future? I would
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025